These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 8260421

  • 1. Cardiology update. Drug therapy.
    Tritschler I.
    Nurs Stand; ; 8(8):52. PubMed ID: 8260421
    [No Abstract] [Full Text] [Related]

  • 2. Essential lessons in cardiogenic shock: epinephrine versus norepinephrine/dobutamine.
    Krenn L, Delle Karth G.
    Crit Care Med; 2011 Mar; 39(3):583-4. PubMed ID: 21330855
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
    Levy B, Perez P, Perny J, Thivilier C, Gerard A.
    Crit Care Med; 2011 Mar; 39(3):450-5. PubMed ID: 21037469
    [Abstract] [Full Text] [Related]

  • 4. [Drug therapy in cardiogenic shock].
    Wenger R.
    Int J Clin Pharmacol; 1973 Apr; 7(2):127-31. PubMed ID: 4147221
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical use of dopamine].
    Goldberg LI, Hsieh YY.
    Internist (Berl); 1978 Jul; 19(7):427-30. PubMed ID: 357329
    [No Abstract] [Full Text] [Related]

  • 6. [Dobutamine, dopamine, and other catecholamine-like substances for myocardial infarct].
    Machii K.
    Nihon Rinsho; 1983 Dec; 41(12):2685-90. PubMed ID: 6674555
    [No Abstract] [Full Text] [Related]

  • 7. [Sympathomimetic amines].
    Benzer H.
    Anaesthesist; 1979 Apr; 28(4):153. PubMed ID: 434429
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of dopamine and norepinephrine in shock.
    Romero CM.
    N Engl J Med; 2010 Jun 17; 362(24):2328; author reply 2330-1. PubMed ID: 20554990
    [No Abstract] [Full Text] [Related]

  • 9. Network Meta-Analysis of the Safety of Drug Therapy for Cardiogenic Shock.
    Liao X, Qian L, Zhang S, Chen X, Lei J.
    J Healthc Eng; 2020 Jun 17; 2020():8862256. PubMed ID: 32802302
    [Abstract] [Full Text] [Related]

  • 10. [Adverse effects of inotropic drugs in hypertrophic cardiomyopathy].
    Pérez-Cimarra C, Font C, Gredilla E, Gilsanz F.
    Rev Esp Anestesiol Reanim; 2007 Jun 17; 54(7):453-4. PubMed ID: 17953346
    [No Abstract] [Full Text] [Related]

  • 11. Dopamine versus norepinephrine in the treatment of shock.
    Nathan Coxford R, Lang E, Dowling S.
    CJEM; 2011 Nov 17; 13(6):395-7. PubMed ID: 22436478
    [Abstract] [Full Text] [Related]

  • 12. Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.
    Goldberg LI, Hsieh YY, Resnekov L.
    Prog Cardiovasc Dis; 1977 Nov 17; 19(4):327-40. PubMed ID: 12536
    [No Abstract] [Full Text] [Related]

  • 13. [Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?].
    Schwertz H, Müller-Werdan U, Prondzinsky R, Werdan K, Buerke M.
    Dtsch Med Wochenschr; 2004 Sep 10; 129(37):1925-30. PubMed ID: 15372372
    [Abstract] [Full Text] [Related]

  • 14. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
    El Mokhtari NE, Arlt A, Meissner A, Lins M.
    Eur J Med Res; 2007 Nov 05; 12(11):563-7. PubMed ID: 18024265
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of epinephrine therapy in shock complicating pulmonary embolism.
    Boulain T, Lanotte R, Legras A, Perrotin D.
    Chest; 1993 Jul 05; 104(1):300-2. PubMed ID: 8325096
    [Abstract] [Full Text] [Related]

  • 16. [Management of cardiogenic shock: Results from a survey in France and Belgium].
    Champion S, Deye N.
    Ann Cardiol Angeiol (Paris); 2017 Apr 05; 66(2):59-65. PubMed ID: 27836099
    [Abstract] [Full Text] [Related]

  • 17. Drug therapy in cardiogenic shock.
    Ramdohr B.
    Int J Clin Pharmacol; 1973 Apr 05; 7(2):118-26. PubMed ID: 4731279
    [No Abstract] [Full Text] [Related]

  • 18. [Differential therapy of cardiogenic shock with dopamine/milrinone in comparison with dopamine/dobutamine].
    Meissner A, Schmelzle T, Simon R.
    Z Kardiol; 1996 Nov 05; 85(11):839-46. PubMed ID: 9064946
    [Abstract] [Full Text] [Related]

  • 19. Inotropic agents in the treatment of cardiogenic shock.
    Bourdarias JP, Dubourg O, Gueret P, Ferrier A, Bardet J.
    Pharmacol Ther; 1983 Nov 05; 22(1):53-79. PubMed ID: 6361798
    [No Abstract] [Full Text] [Related]

  • 20. Shock in elderly persons.
    Levy H, Jastremski MS.
    Compr Ther; 1984 Jul 05; 10(7):48-56. PubMed ID: 6430635
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.